Annual Report FY 2025-26 and 37th AGM Notice filed with BSE

Pat Growth 25pctRelated Party TransactionsResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.6%Reaction day

₹129.00

prior close

₹133.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.9%+2.6% vs market

Specialty Chemicals peers, median of 93sector+1.0%+3.6% vs sector

On the reaction day the stock moved 2.6 pts more than Nifty Microcap 250 and 3.6 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.6+1.9+2.6+1.0+3.6

Next day

+6.5+3.3+3.1+1.7+4.8

+2.6+3.5-0.8+2.0+0.6

+3.9+2.4+1.4+1.5+2.4

+3.9+3.1+0.8+1.7+2.1

+1.8+2.6-0.8+2.4-0.6

+5.4+2.1+3.3+1.9+3.6

15d

+7.7+0.9+6.8+1.2+6.5

+38.1+5.5+32.6+4.0+34.1

+31.7+8.1+23.7+6.9+24.8

+41.0+3.5+37.6+3.4+37.7

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 93Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Resonance Specialties filed its 37th Annual Report for FY 2025-26 with the AGM notice. The 37th AGM is on August 4, 2026 via video conferencing. Total income rose to Rs 9,188.93 lacs (up about 17 percent YoY). Profit after tax jumped 58 percent to Rs 1,039.58 lacs from Rs 656.62 lacs, lifting EPS to Rs 9.01 from Rs 5.69. The company seeks shareholder approval for related party transactions with Kaygee Laboratories up to Rs 40 crores, reappointment of statutory auditors Kailash Chand Jain and Co for 5 years, and declaration of dividend with record date July 28, 2026.

Likely market impact

Strong profit growth and proposed dividend signal improving performance. RPT approval with related party Kaygee Laboratories up to Rs 40 crores needs shareholder nod.